Target intelligence / Profile preview

SIX homeobox 6 (SIX6)

Target
SIX6
Molecular classification
Transcription factor, Homeobox protein
01

Overview

SIX homeobox 6 (SIX6) is a homeobox transcription factor that plays a critical role in eye development, particularly in the regulation of retinal progenitor cell proliferation and differentiation. It is a member of the evolutionary conserved SIX family, defined by a homeobox DNA-binding domain and the SIX protein-protein interaction domain. SIX6 expression is essential for early retinal determination, and disruption results in significant eye malformations. Mutations in SIX6 are associated with congenital disorders such as microphthalmia with cataract type 2, and genetic variants have been linked to increased risk of primary open-angle glaucoma. While primarily acting as a regulator in embryogenesis and ocular development, aberrant expression or epigenetic regulation of SIX6 and related SIX family members has been implicated in oncogenesis, though SIX6 itself is not currently a direct therapeutic target.

Other names
Homeobox protein SIX6OPTX2Six9Homeodomain protein OPTX2Optic homeobox 2Sine oculis homeobox homolog 6MCOPCT2ODRMDsine oculis homeobox protein 6sine oculis homeobox-like protein 6
02

Mechanism of action

Not applicable (no drugs specifically target SIX6 reported to date)

03

Biological functions

Regulation of eye developmentRegulation of retinal progenitor cell proliferation and differentiationCell cycle control (especially in developmental contexts)Regulation of apoptosis (cell death)Regulation of gene expression during organogenesis
04

Disease associations

Congenital eye disorders (e.g., microphthalmia with cataract)Glaucoma (risk alleles implicated in disease)Cancer (reactivation and dysregulation reported, especially in developmental gene regulation)
05

Safety considerations

Targeting transcription factors like SIX6 could disrupt normal developmental and cellular regulatory processes, leading to significant unintended consequencesGermline mutations or aberrant expression are linked to developmental eye defects and possibly increased risk for some cancers, indicating concerns with loss/gain of function
06

Biomarkers

Variants of SIX6 suggested as genetic risk biomarkers for primary open-angle glaucoma and certain congenital ocular disorders

Beyond the preview

Go deeper on SIX homeobox 6 (SIX6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIX homeobox 6 (SIX6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call